+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
G-Protein Coupled Receptors Market - Global Forecast 2026-2032- Product Image
G-Protein Coupled Receptors Market - Global Forecast 2026-2032- Product Image
Sale

G-Protein Coupled Receptors Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887241
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The G-Protein Coupled Receptors Market is projected to reach USD 4.58 Billion in 2026. It is expected to continue growing at a CAGR of 9.79%, reaching USD 8.15 Billion by 2032.

G-Protein-Coupled Receptors: Executive Summary

G-protein-coupled receptors (GPCRs) are seven-transmembrane cell-surface proteins that convert extracellular signals into intracellular responses. They regulate processes including neurotransmission, hormone action, immune signaling, sensory perception, and cardiovascular function. Their established biological relevance and tractability as drug targets continue to support research across therapeutics, diagnostics, structural biology, and pharmacology. This summary focuses on evidence-based scientific and industry developments without presenting market estimates or forecasts.

From Ligand Discovery to Functional Receptor Control

GPCR research is shifting from conventional ligand screening toward functional control of receptor signaling. Advances in cryo-electron microscopy, high-resolution structural methods, biosensors, and cellular assays are improving understanding of receptor conformations, ligand bias, allosteric modulation, dimerization, trafficking, and tissue-specific responses. These developments are helping researchers distinguish efficacy from pathway selectivity and are supporting more precise approaches to safety and therapeutic design. Regulatory and translational attention is also increasingly focused on reproducible pharmacology, biomarker definition, and clinically meaningful differentiation.

Artificial Intelligence Accelerates GPCR Research Workflows

Artificial intelligence is contributing to GPCR research through protein-structure prediction, ligand-property modeling, virtual screening, image analysis, experiment prioritization, and interpretation of high-dimensional pharmacology data. Its strongest practical value is in narrowing experimental options and identifying relationships across sequence, structure, signaling, and phenotype datasets. Human validation remains essential because model outputs can reflect incomplete training data, assay-specific artifacts, or limited representation of receptor conformational states. Effective adoption therefore depends on curated datasets, transparent evaluation, laboratory confirmation, and integration with medicinal chemistry and translational biology.

Regional Insights: Complementary Strengths Across the Global GPCR Ecosystem

North America combines substantial biomedical research capacity, advanced screening infrastructure, and strong translation between academic laboratories and therapeutic development. Europe benefits from deep structural biology, pharmacology, and cross-border research networks, while Asia-Pacific is expanding capabilities in drug discovery, genomics, and precision medicine. Latin America contributes expertise in biodiversity, clinical research, and disease-focused investigation, although infrastructure and funding vary by country. The Middle East is strengthening research institutions and biotechnology programs, and Africa presents important opportunities in infectious disease, population health, and locally relevant pharmacology alongside continuing needs for laboratory capacity and data resources.

Group Insights: Research and Regulatory Priorities Across Major Alliances

ASEAN countries are developing complementary capabilities in biomedical research, clinical studies, and pharmaceutical manufacturing, with collaboration helping address differences in infrastructure. BRICS members bring large scientific communities, diverse disease burdens, and growing interest in domestic innovation, while the European Union benefits from coordinated research and regulatory frameworks. The G7 remains influential in advanced life-science research, standards, and translational development. GCC countries are investing in research infrastructure, health innovation, and diversification, and NATO members support extensive biomedical collaboration through national and multinational scientific networks. Across all groups, data interoperability, shared standards, and responsible use of emerging technologies are recurring priorities.

Country Insights: Distinct Capabilities Shape GPCR Research

Australia contributes strengths in biomedical science, structural biology, and translational research. Brazil and Mexico offer substantial disease-diverse research environments and expanding pharmaceutical capabilities. Canada supports discovery through strong academic and public research institutions. China and India are broadening capabilities across medicinal chemistry, biologics, computational science, and manufacturing. Japan and South Korea are notable for advanced life-science technology and translational research, while France, Germany, Italy, Spain, and the United Kingdom contribute established pharmacology, structural biology, clinical research, and regulatory expertise. Russia maintains scientific capacity in molecular and biomedical research. The United States remains a major center for receptor biology, drug discovery, clinical translation, and biotechnology. Country-level progress is shaped by research funding, access to samples and databases, regulatory alignment, and workforce development.

Action Priorities for GPCR Industry Leaders

Industry leaders should prioritize receptor mechanisms that are supported by reproducible human biology and clinically relevant biomarkers rather than relying solely on binding affinity. Investment should combine structural methods, functional assays, patient-derived models, and carefully designed translational studies. Organizations can improve productivity by establishing data standards, documenting assay context, validating artificial-intelligence outputs experimentally, and using orthogonal methods to confirm selectivity and pathway behavior. Partnerships with academic, clinical, and regional research institutions can expand access to specialized models and diverse biological data. Portfolio decisions should also account for formulation, tissue exposure, safety pharmacology, manufacturing feasibility, and regulatory evidence requirements from the outset.

Research Methodology: Evidence-Led Synthesis of GPCR Developments

This executive summary uses the supplied market definition-G-protein-coupled receptors-as the analytical scope. Findings are synthesized from established scientific principles and widely documented developments in GPCR structural biology, pharmacology, drug discovery, artificial intelligence, translational medicine, and regional research systems. The approach separates biological facts from interpretation, avoids unsupported quantitative claims, and compares geographies through research capability, infrastructure, collaboration, and policy context. It does not provide market sizing, market shares, forecasts, or company-specific assessments.

Conclusion: Precision Signaling Remains the Strategic Direction

GPCR science is progressing from broad receptor activation toward precise, context-dependent control of signaling. Structural insight, functional pharmacology, computational methods, and better translational models are converging to improve discovery and therapeutic design. Regional and country capabilities remain diverse, making collaboration and data connectivity important complements to internal research strength. Leaders that pair artificial intelligence with rigorous experimental validation, clinically relevant biomarkers, and disciplined development processes will be best positioned to convert GPCR biology into differentiated medical advances.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. G-Protein Coupled Receptors Market, by Receptor Class
7.1. Introduction
7.2. Class A Rhodopsin
7.2.1. Amino Acid Receptors
7.2.2. Chemokine Receptors
7.2.3. Lipid Receptors
7.2.4. Monoamine Receptors
7.2.5. Opsin Receptors
7.2.6. Peptide Receptors
7.3. Class B Secretin
7.4. Class C Metabotropic Glutamate
7.5. Class F Frizzled/Taste 2
7.6. Orphan Receptors
8. G-Protein Coupled Receptors Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Cns Disorders
8.4. Gastrointestinal Disorders
8.5. Inflammation
8.6. Metabolic Disorders
8.7. Oncology
8.7.1. Breast Cancer
8.7.2. Colorectal Cancer
8.7.3. Leukemia
8.7.4. Lung Cancer
8.7.5. Prostate Cancer
8.8. Pain Management
8.9. Respiratory Disorders
9. G-Protein Coupled Receptors Market, by Application
9.1. Introduction
9.2. Clinical Trials
9.2.1. Phase I
9.2.2. Phase II
9.2.3. Phase III
9.3. Diagnostics
9.4. Drug Discovery
9.5. Preclinical Development
10. G-Protein Coupled Receptors Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Diagnostic Laboratories
10.5. Pharmaceutical And Biotech Companies
11. G-Protein Coupled Receptors Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. G-Protein Coupled Receptors Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. G-Protein Coupled Receptors Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abalone Bio, Inc.
15.2. Abcam plc
15.3. Addex Therapeutics Ltd.
15.4. Becton, Dickinson and Company
15.5. BioInvenu, Inc.
15.6. Cisbio Bioassays SAS
15.7. Confo Therapeutics NV
15.8. Corning Incorporated
15.9. Crinetics Pharmaceuticals, Inc.
15.10. Domain Therapeutics SA
15.11. Enzo Life Sciences, Inc.
15.12. Escient Pharmaceuticals, Inc.
15.13. Eurofins Scientific SE
15.14. Merck KGaA
15.15. Molecular Devices, LLC
15.16. OKYO Pharma Limited
15.17. Orion Biotechnology
15.18. OSE Immunotherapeutics SA
15.19. PerkinElmer Inc.
15.20. Promega Corporation
15.21. QIAGEN GmbH
15.22. Septerna, Inc.
15.23. Sosei Group Corporation
15.24. Tectonic Therapeutic, Inc.
15.25. Teon Therapeutics, Inc.
15.26. Thermo Fisher Scientific Inc.
15.27. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global G-Protein Coupled Receptors Market, Years Considered for the Study
FIGURE 2. Global G-Protein Coupled Receptors Market, Research Design
FIGURE 3. Global G-Protein Coupled Receptors Market, Research Framework
FIGURE 4. Global G-Protein Coupled Receptors Market, Data Triangulation
FIGURE 5. Global G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
FIGURE 6. Global G-Protein Coupled Receptors Market Size, by Receptor Class, 2025 vs 2032 (%)
FIGURE 7. Global G-Protein Coupled Receptors Market Size, by Receptor Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 9. Global G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global G-Protein Coupled Receptors Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global G-Protein Coupled Receptors Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global G-Protein Coupled Receptors Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global G-Protein Coupled Receptors Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global G-Protein Coupled Receptors Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global G-Protein Coupled Receptors Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global G-Protein Coupled Receptors Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global G-Protein Coupled Receptors Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global G-Protein Coupled Receptors Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global G-Protein Coupled Receptors Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global G-Protein Coupled Receptors Market Segmentation & Coverage
TABLE 2. Global G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 3. Global G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 4. Global Class A Rhodopsin Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Class A Rhodopsin Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Class A Rhodopsin Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Amino Acid Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Amino Acid Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Amino Acid Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Chemokine Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Chemokine Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Chemokine Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Lipid Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Lipid Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Lipid Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Monoamine Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Monoamine Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Monoamine Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Opsin Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Opsin Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Opsin Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Peptide Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Peptide Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Peptide Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Class B Secretin Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Class B Secretin Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Class B Secretin Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Class C Metabotropic Glutamate Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Class C Metabotropic Glutamate Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Class C Metabotropic Glutamate Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Class F Frizzled/Taste 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Class F Frizzled/Taste 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Class F Frizzled/Taste 2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Orphan Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Orphan Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Orphan Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 38. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Cns Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Cns Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Cns Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Gastrointestinal Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Gastrointestinal Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Gastrointestinal Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Leukemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Leukemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Leukemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Respiratory Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Respiratory Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Respiratory Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Global Clinical Trials Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Clinical Trials Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Clinical Trials Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Phase I Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Phase I Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Phase I Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Phase II Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Phase II Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Phase II Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Phase III Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Phase III Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Phase III Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Preclinical Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Preclinical Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Preclinical Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Pharmaceutical And Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Pharmaceutical And Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Pharmaceutical And Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. North America G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. North America G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 123. North America G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 124. North America G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 125. North America G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 126. North America G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. North America G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 128. North America G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Latin America G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Latin America G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 131. Latin America G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 132. Latin America G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 133. Latin America G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 134. Latin America G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Latin America G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 136. Latin America G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Europe G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Europe G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 139. Europe G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 140. Europe G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 141. Europe G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 142. Europe G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Europe G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 144. Europe G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Middle East G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Middle East G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 147. Middle East G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 148. Middle East G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 149. Middle East G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 150. Middle East G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Middle East G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 152. Middle East G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Africa G-Protein Coupled Receptors Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Africa G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 155. Africa G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 156. Africa G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 157. Africa G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 158. Africa G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Africa G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 160. Africa G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Global G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. ASEAN G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 164. ASEAN G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 165. ASEAN G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 166. ASEAN G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 167. ASEAN G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. ASEAN G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 169. ASEAN G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. GCC G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. GCC G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 172. GCC G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 173. GCC G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 174. GCC G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 175. GCC G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. GCC G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 177. GCC G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. European Union G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. European Union G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 180. European Union G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 181. European Union G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 182. European Union G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 183. European Union G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. European Union G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 185. European Union G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. BRICS G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. BRICS G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 188. BRICS G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 189. BRICS G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 190. BRICS G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 191. BRICS G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. BRICS G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 193. BRICS G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. G7 G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. G7 G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 196. G7 G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 197. G7 G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 198. G7 G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 199. G7 G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. G7 G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 201. G7 G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. NATO G-Protein Coupled Receptors Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. NATO G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 204. NATO G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 205. NATO G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 206. NATO G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 207. NATO G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. NATO G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 209. NATO G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Global G-Protein Coupled Receptors Market Size, by Country, 2017-2032 (USD Million)
TABLE 211. United States G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 212. United States G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 213. United States G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 214. United States G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 215. United States G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 216. United States G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. United States G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 218. United States G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Canada G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 220. Canada G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 221. Canada G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 222. Canada G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 223. Canada G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 224. Canada G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Canada G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 226. Canada G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Mexico G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 228. Mexico G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 229. Mexico G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 230. Mexico G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 231. Mexico G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 232. Mexico G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Mexico G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 234. Mexico G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Brazil G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 236. Brazil G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 237. Brazil G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 238. Brazil G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 239. Brazil G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 240. Brazil G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Brazil G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 242. Brazil G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. United Kingdom G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 244. United Kingdom G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 245. United Kingdom G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 246. United Kingdom G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 247. United Kingdom G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 248. United Kingdom G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. United Kingdom G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 250. United Kingdom G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Germany G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 252. Germany G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 253. Germany G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 254. Germany G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 255. Germany G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 256. Germany G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Germany G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 258. Germany G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. France G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 260. France G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 261. France G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 262. France G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 263. France G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 264. France G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. France G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 266. France G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Russia G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 268. Russia G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 269. Russia G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 270. Russia G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 271. Russia G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 272. Russia G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Russia G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 274. Russia G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Italy G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 276. Italy G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 277. Italy G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 278. Italy G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 279. Italy G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 280. Italy G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Italy G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 282. Italy G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Spain G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 284. Spain G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 285. Spain G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 286. Spain G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 287. Spain G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 288. Spain G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Spain G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 290. Spain G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. China G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 292. China G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 293. China G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 294. China G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 295. China G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 296. China G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. China G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 298. China G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. India G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 300. India G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 301. India G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 302. India G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 303. India G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 304. India G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. India G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 306. India G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. Japan G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 308. Japan G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 309. Japan G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 310. Japan G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 311. Japan G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 312. Japan G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. Japan G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 314. Japan G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. Australia G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 316. Australia G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 317. Australia G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 318. Australia G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 319. Australia G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 320. Australia G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. Australia G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 322. Australia G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. South Korea G-Protein Coupled Receptors Market Size, 2017-2032 (USD Million)
TABLE 324. South Korea G-Protein Coupled Receptors Market Size, by Receptor Class, 2017-2032 (USD Million)
TABLE 325. South Korea G-Protein Coupled Receptors Market Size, by Class A Rhodopsin, 2017-2032 (USD Million)
TABLE 326. South Korea G-Protein Coupled Receptors Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 327. South Korea G-Protein Coupled Receptors Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 328. South Korea G-Protein Coupled Receptors Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. South Korea G-Protein Coupled Receptors Market Size, by Clinical Trials, 2017-2032 (USD Million)
TABLE 330. South Korea G-Protein Coupled Receptors Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. Global G-Protein Coupled Receptors Market Share, by Key Player, 2025
TABLE 332. Global G-Protein Coupled Receptors Market, Key Experts

Companies Mentioned

  • Abalone Bio, Inc.
  • Abcam plc
  • Addex Therapeutics Ltd.
  • Becton, Dickinson and Company
  • BioInvenu, Inc.
  • Cisbio Bioassays SAS
  • Confo Therapeutics NV
  • Corning Incorporated
  • Crinetics Pharmaceuticals, Inc.
  • Domain Therapeutics SA
  • Enzo Life Sciences, Inc.
  • Escient Pharmaceuticals, Inc.
  • Eurofins Scientific SE
  • Merck KGaA
  • Molecular Devices, LLC
  • OKYO Pharma Limited
  • Orion Biotechnology
  • OSE Immunotherapeutics SA
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN GmbH
  • Septerna, Inc.
  • Sosei Group Corporation
  • Tectonic Therapeutic, Inc.
  • Teon Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

G-Protein Coupled Receptors Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

G-Protein Coupled Receptors Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 350 Pages
  • Global
From
G-Protein Coupled Receptors Market Size, Share, Trends and Forecast by Product, Assay Type, Application, and Region, 2026-2034 - Product Image

G-Protein Coupled Receptors Market Size, Share, Trends and Forecast by Product, Assay Type, Application, and Region, 2026-2034

  • Report
  • 136 Pages
  • Global
From
G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2026 - Product Image

G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2026

  • Report
  • 250 Pages
  • Global
From
G-Protein Coupled Receptors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

G-Protein Coupled Receptors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report - Product Image

G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report

  • Report
  • 359 Pages
  • Global
From

About the G Protein Coupled Receptors Market

G Protein Coupled Receptors (GPCRs) are a class of proteins that are involved in a wide range of physiological processes, including cell signaling, metabolism, and homeostasis. They are the most abundant type of membrane receptor in the human body, and are involved in the regulation of many cellular processes. GPCRs are the target of many drugs, and are the focus of much research in the field of proteomics. Proteomics is the study of the structure and function of proteins, and GPCRs are a major focus of proteomics research. Proteomics research has enabled the development of new drugs and therapies that target GPCRs, and has also enabled the development of new diagnostic tools for diseases that involve GPCRs. Companies in the GPCR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.